Private Equity
SR One Capital Management, a transatlantic biotech VC firm that spun out of GlaxoSmithKline, has closed on more than $600 million for its second fund, beating its $500 million target.
1 min read · 28 March 2023
The firm's network boasts more than 60 investors, including Dragonfly Capital, Eniac Ventures, Multicoin Capital and SV Angel.
1 min read · 22 March 2023
Freestyle Ventures and Builders VC led the round.
2 min read · 22 March 2023
The Los Angeles-based firm sees opportunity where institutional capital is 'scared' to go.
3 min read · 20 March 2023
The original target was $150 million.
1 min read · 02 March 2023
8VC Fund V's limited partners include top endowments and pensions, enterprising families, strategic corporations, and dozens of entrepreneurs.
1 min read · 02 March 2023
New Form Capital has held a second close just under its target of $75m as it says it will pick up its pace of investment in blockchain technologies.
4 min read · 02 March 2023
Fund II's backers include Polygon, Ripple, Octava, NEO Global Capital, Appworks, GSR, LD Capital, Metavest Capital and family offices.
2 min read · 01 March 2023
SixThirty Ventures has closed on $66 million for its third fund, which will invest in early-stage companies at the intersection of finance, health and privacy.
1 min read · 28 February 2023
Bain Capital Ventures has raised a total of $1.9 billion across two new venture funds, more than twice as much as it raised for a previous flagship fund.
2 min read · 28 February 2023
